{
    "id": "dbpedia_3328_2",
    "rank": 88,
    "data": {
        "url": "https://www.bromatech.it/approfondimenti",
        "read_more_link": "",
        "language": "en",
        "title": "Approfondimenti",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://www.bromatech.it/images/template/logo_bromatech_orizzontale.svg",
            "https://www.bromatech.it/images/template/logo_bromatech_esteso_white.svg",
            "https://www.bromatech.it/templates/yootheme/cache/a6/BG_APPROFONDIMENTI_01_2000px-a678f720.jpeg",
            "https://www.bromatech.it/templates/yootheme/cache/6a/BG_APPROFONDIMENTI_02_2000px-6af4da19.jpeg",
            "https://www.bromatech.it/templates/yootheme/cache/ed/BG_APPROFONDIMENTI_03_2000px-ed83b050.jpeg",
            "https://www.bromatech.it/templates/yootheme/cache/b1/BG_APPROFONDIMENTI_04_2000px-b194d790.jpeg",
            "https://www.bromatech.it/templates/yootheme/cache/dc/001-02-dcc4a02c.jpeg",
            "https://www.bromatech.it/templates/yootheme/cache/dc/001-02-dcc4a02c.jpeg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Ricerca e sviluppo di integratori alimentari per la salute a base di probiotici. La nostra azienda sviluppa i propri prodotti con la collaborazione di un esteso",
        "meta_lang": "it",
        "meta_favicon": "/images/template/favicon.png",
        "meta_site_name": "",
        "canonical_link": "https://www.bromatech.it/approfondimenti",
        "text": "Bibliografia\n\nA L D'Souza, Chakravarthi Rajkumar, Jonathan Cooke, Christopher J Bulpitt Probiotics in prevention of antibiotic associated diarrhoea: meta - analysis BMJ VOLUME 324 8 JUNE 2002\n\nA. Capolupo, W. J. Freeman and G. Vitiello, Dissipation of 'dark energy' by cortex in knowledge retrieval, Phys. of Life Reviews 10, 85 (2013).\n\nA. Di Mauro, J. Neu, G. Riezzo et al., “Gastrointestinal function development and microbiota,” Italian Journal of Pediatrics, vol. 39, no. 1, article 15, 2013;\n\nA. Youakim and M. Ahdieh, “Interferon-???? decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 276, no. 5, pp. G1279–G1288, 1999\n\nA. Zeyner and E. Boldt, “Effects of a probiotic Enterococcus faecium strain supplemented from birth to weaning on diarrhea patterns and performance of piglets,” Journal of Animal Physiology and Animal Nutrition, vol. 90, no. 1-2, pp. 25–31, 2006\n\nA.H. Knoll, S.B. Carroll, Early animal evolution: emerging views from comparative biology and geology, Science 284 (1999) 2129–2137\n\nA.M. Galea, A.J. Brown / Free Radical Biology & Medicine 47 (2009) 880–889\n\nAagaard K, Petrosino J, KeitelW, Watson M, Katancik J, Garcia N, et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J 2013; 27: 1012–22\n\nAbdel-Rahman MA, Tashiro Y, Sonomoto K, Recent advances in lactic acid production by microbial fermentation processes, “Biotechnol Adv” 2013, Nov, 31 (6): 877-902. doi: 10.1016/j.biotechadv.2013.04.002. Epub 2013 Apr 24.\n\nAbouesh, A., Stone, C. & Hobbs, W. R. Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J. Clin. Psychopharmacol. 22, 71 - 81 (200 2).\n\nAbraham C. Cho J.H. (2009). Mechanisms of Disease, Inflammatory Bowel Disease. N. Engl. J. Med, 361: 2066-2078.\n\nAbraham, S.N. & St John, A.L. Mast cell-orchestrated immunity to pathogens. Nature reviews. Immunology 10, 440-452 (2010).\n\nAbu-Amero, K. K.; Miles, R. J.; Halablab, M. A. Cholesterol protects Acholeplasma laidlawii against oxidative damage caused by hydrogen peroxide. Vet. Res. Commun. 29:373–380; 2005\n\nAcid and Its Relationship to Major Depression. International Journal of Anthropology, 24, 201-220.\n\nAdachi K, Nanba H, Otsuka M, Kuroda H. Blood pressure-lowering activity present in the fruit body of Grifola frondosa (maitake):I. Chem Pharm Bull 1988;36:1000-1006.\n\nAdachi Y, Ohno N, Yadomae T. Activation of murine kupffer cells by administration with gel-forming (1->3)-beta-Dglucan from Grifola frondosa. Biol Pharm Bull 1998;21:278-283.\n\nAdachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1->3)-beta-Dglucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull 1994;17:1554- 1560.\n\nAdachi Y. Moore L.E. Bradford B.U. Gao W. Thurman R.G. (1995). Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology. 108: 218 - 224.\n\nAdam C Bastidas, Michael S Deal, Jon M Steichen, Malik M Keshwani,Guo Y, Susan S, Taylor A, Role of N-Terminal Myristylation in the Structure and Regulation of cAMP-Dependent Protein Kinase, “J Mol Biol”, 2012, Sep 14, 422 (2): 215-229. Published online 2012 May 19. doi: 10.1016/j.jmb.2012.05.021.\n\nAdams CA,The probiotic paradox: live and dead cells are biological response modifiers, “Nutr Res Rev”, 2010, Jun, 23 (1): 37-46. doi: 10.1017/s0954422410000090. epub 2010 apr 20.\n\nAdawi D. Ahrné S. Molin G. Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int J Food Microbiol, 2001, 70: 213-20.\n\nAddis P.B. (1990). Coronary heart disease. Food Nutr News, 62: 7-10.\n\nAddolorato G, et al. (1998) Anxiety and depression: A common feature of health care seeking patients with irritable bowel syndrome and food allergy. Hepatogastroenterology 45:1559–1564.\n\nAdeline Divoux, Sandrine Moutel, Christine Poitou, 14 I diritti di riproduzione, anche parziale, sono di esclusiva proprietà della SIBS. Danie` le Lacasa, Nicolas Veyrie, Abdelhalim Aissat, Michel Arock, Miche` le Guerre-Millo, and Karine Clement. Mast Cells in Human Adipose Tissue: Link with Morbid Obesity, Inflammatory Status, and Diabetes. J Clin Endocrinol Metab 97: E1677–E1685, 2012;\n\nAfri M., Ehrenberg B., Talmon Y., Schmidt J., Cohen Y., Frimer AA. (2004). Active oxygen chemistry within the liposomal bilayer: Part III: Locating Vitamin E, ubiquinol and ubiquinone and their derivatives in the lipid bilayer. Chem Phys Lipids, 131: 107-121.\n\nAgerbaek M. Gerdes L.U. and Richelsen B. (1995). Hypocholesterolemic effect of a new fermented milk product in healthy middle-aged men. Eur. J. Clin. Nutr, 49: 346 - 352.\n\nAgergolm-Larsen L. Bell M.L. Grunwald G.K. Astrup A. (2000). The Effect of a Probiotic Milk Product on Plasma Cholesterol: A Meta-analysis of Short Term Intervention Studies. European Journal of Clinical Nutrition, 54: 856-60.\n\nAguilar E.C. et al. Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFkB activation. Nutrition, Metabolism & Cardiovascular Diseases (2014) 24, 606-613.\n\nAhn Y.T. Kim G.B. Lim K.S. Baek Y.T. and Kim H.U. (2003). Deconjugation of Bile Salts by Lactobacillus acidophilus Isolates. International Dairy Journal. 13: 303-311.\n\nAhonen A. Kyosola K. Penttila O. (1976). Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon. Ann Clin Res, 8: 1 - 7.\n\nAhrne S, Nobaek S, Jeppsson B, et al. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol. 1998;85:88–94\n\nAichbhaumik N, Zoratti EM, Strickler R, et al. Prenatal exposure to household pets influences fetal immunoglobulin E production. Clin Exp Allergy 2008;38(11):1787 - 1794;\n\nAird W.C. (2007). Phenotypic Heterogeneity of the endothelium. I. structure, function and mechanisms. Circulation research, 100: 158-173.\n\nAJOB Neuroscience, 4,4: 1-2. doi 10.1080/21507740.2013.836337.\n\nAkhtar S. (2013). Alcohol, Gut Microbiota and Epithelial Barrier: An Interdependent Relationship. J Alcoholism Drug Depend. 1: e104. doi:10.4172/ jaldd.1000e104.\n\nAl Saif N, Brazier JS. The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol 1996;45(2):133–7;\n\nAlakomi HL, Skytta E, Saarela M, Mattila-Sandholm T, Latva- Kala K, Helander IM. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol 66: 2001 - 2005, 2000.\n\nAlberini C.M., Ghirardi M., Metz R., Kandel E.R. (1994) CIEBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76: 1099-1 114.\n\nAlcoholism; Alcohol Alters Prefrontal Cortex Activity Through Ion Channel Disruption. NewsRx Health. (2008) http:// www.newsrx.com/newsletters/ Biotech-Week.html\n\nAlhede M, Bjarnsholt T, Givskov M, Alhede M, Pseudomonas aeruginosa biofilms: mechanisms of immune evasion, “Adv Appl Microbiol”, 2014, 86: 1-40. doi: 10.1016/B978-0-12-800262-9.00001-9.\n\nAllan EJ, Hoischen C, Gumpert J. Bacterial L-forms. Adv Appl Microbiol 2009; 68: 1–39;\n\nAllen EK, Koeppel AF, Hendley JO, Turner SD, Winther B, Sale MM, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, “Microbiome”, 2014, Jun 25, 2: 22. doi: 10.1186/2049-2618-2-22. eCollection 2014.\n\nAllen J, Halvorsen, R., and RASENICK MM (2007)\"Lipid Raft Microdomains and Neurotransmitter Signaling\" NATURE Reviews Neuroscience 8:128-140\n\nAllen J.A. Halverson-Tamboli R.A. Rasenick M.M. (2007). Lipid raft micro domains and neurotransmitter signaling. Nat. Rev. Neurosci, 8: 128- 140.\n\nAllen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhea [review]. Cochrane Database Syst Rev. 2004;(2):CD003048;\n\nAlmond M. Depression and inflammation: examining the link. Current Psychiatry. 2013; 12:24-32;\n\nAlonso A, Nettleton JA, Ix JH, de Boer IH, Folsom AR, Bidulescu A, et al. Dietary phosphorus, blood pressure and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis. Hypertension 2010;55:776-84.\n\nAltieri C, Bevilacqua A, Cardillo D, Sinigaglia M. Antifungal activity of fatty acids and their monoglycerides against Fusarium spp. in a laboratory medium. International Journal of Food Science and Technology. 2009;44:242-245;\n\nAltintasMM, Rossetti MA, Nayer B, Puig A, Zagallo P, Ortega LM, Johnson KB, McNamara G, Reiser J, Mendez AJ, Nayer A 2011 A Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis 10:198;\n\nAmar J, Lange C, Payros G, et al. Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One 2013; 8: e54461;\n\nAmar J, Serino M, Lange C, et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 2011; 54: 3055–61;\n\nAmar S, Engelke M. Periodontal innate immune mechanisms relevant to atherosclerosis. Mol Oral Microbiol 2014;\n\nAminzadeh MA, Nicholas SB, Norris KC et al. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo - interstitial nephropathy. Nephrol Dial Transplant 2013; 28: 2038–2045.\n\nAmmit, A.J., Bekir, S.S., Johnson, P.R., Hughes, J.M., Armour, C.L., Black, J.L., 1997. Mastcell numbers are increased in the smooth muscle of human sensitized isolatedbronchi. Am. J. Respir. Crit. Care Med. 155, 1123–1129;\n\nAmsel R, Totten PA, Spiegel CA, Chen KC,Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14–22\n\nAnastasi G. et al. Trattato di Anatomia Umana. Edi-Ermes, 2006.\n\nAnastasia I. Petra et al, Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clinical Therapeutics 2015.\n\nAncuta P. Kamat A. Kunstman K.J. et al. (2008). Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One. 3: e2516.\n\nAnda R.F. Williamson D.F. Jones D. Macera C. Eaker E. Glassman A.H. Marks J. (1993). Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology, 4: 285-294.\n\nAnderson C.F. Mosser D.M. (2002). A novel phenotype for an activated macrophage: The type 2 activated macrophage. J. Leukoc. Biol, 72: 101 - 106.\n\nAnderson G.M. Cook E.H. Jr. Blakely R.D. (2009). Serotonin rising. N Engl J Med, 360(24): 2580.\n\nAnderson J.W. Gilliland S.E. (1999). Effect of Fermented Milk (Yogurt) Containing Lactobacillus acidophilus L1 on Serum Cholesterol Hypercholesterolemic Humans. Journal of the American College of Nutrition, 18: 43-50.\n\nAnderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of followup from the Framingham study. JAMA 1987; 24; 257(16):2176-80.\n\nAnderson, R. C., Cookson, A. L., MacNabb, W. C., Kelly, W. J., & Roy, N.C. (2010). Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiology Letters 309, 184–192;\n\nAndoh A, Fujiyama Y, Araki Y, Kimura T, Tsujikawa T, Bamba T (2001). Role of complement activation and mast cell degranulation in the pathogenesis of rapid intestinal ischemia/reperfusion injury in rats. Digestion. 63:103-107;\n\nAndrade - Oliveira V, Amano MT, Correa - Costa M et al. Gut bacteria products prevent AKI induced by ischemia - reperfusion. J Am Soc Nephrol 2015; pii: ASN.2014030288\n\nAndrew W. Campbell, Autoimmunity and the Gut. Autoimmune Diseases 2014.\n\nAndriantsoanirina V, Allano S, Butel MJ, Aires J, Tolerance of Bifidobacterium human isolates to bile, acid and oxygen, “Anaerobe” 2013, Jun, 21: 39-42. doi: 10.1016/j.anaerobe.2013.04.005. Epub 2013 Apr 15\n\nAnekella K, Orsat V, Shelf life stability of Lactobacilli encapsulated in raspberry powder: insights into non-dairy probiotics, “Int J Food Sci Nutr”, 2014, Jun, 65 (4): 411-18. doi: 10.3109/09637486.2013.869793. Epub 2014 Jan 20.\n\nAnisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 2008;85:1 - 74.\n\nAnsorena D. Barriuso B. Cardenia V. Astiasaran I. Lercker G. Rodriguez-Estrada M.T. (2013). Thermo-oxidation of cholesterol: effect of the unsaturation degree of the lipid matrix. Publicado en: Ansorena D, Barriuso B, Cardenia V, Astiasaran I, Lercker G, Rodriguez-Estrada MT. Thermo-oxidation of cholesterol: effect of the unsaturation degree of the lipid matrix. Food Chem (Epub May 24);141(3):2757-2764.\n\nAnstey K.J. Jorm A.F. Reglade-Meslin C. et al. (2006). Weekly Alcohol Consumption, Brain Atrophy, and White Matter Hyperintensities in a Community-Based Sample Aged 60 to 64 Years. Psychosomatic Medicine, 68: 778-785.\n\nAntoine Louveau et al, Structural and functional features of central nervous system lymphatic vessels. Nature 2015\n\nAntonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999; 180: 1950–6.\n\nApodaca G. (2002). Modulation of membrane traffic by mechanical stimuli. AJP-Renal Physiol, 282: F179-F190.\n\nard/record.url?eid=2-s2.0-84927704265&partnerID=tZOtx3y1.\n\nAries V. Hill M.J. (1970). Degradation of Steroids by Intestinal Bacteria. Biochimica and Biophysica Acta, 202: 526-534.\n\nAronsson B, Barany P, Nord CE, Nyström B, Stenvinkel P: Clostridium difficile - associated diarrhoea in uremic patients. Eur J Clin Microbiol 6: 352–356, 1987.\n\nArora R.C. Meltzer H.Y. (1989). Increased serotonin 2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci. 44: 725-734.\n\nArsenau K.O. Cominelli F. (2009). Leukocytaferesis in ulcerative colitis, a possible alternative to biological therapy? Dig. Liver Dis, 41: 551-552.\n\nArthur J.C. Jobin C. The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis, 2011, 17: 396-409.\n\nArthur L. Greil, Thomas A. Leitko, Karen L. Porter. Infertility: His and Hers Gender & Society. 1988. Volume: 2 issue: 2, page(s): 172-199\n\nAsaduzzaman SM, Sonomoto K: Lantibiotics: diverse activities and unique modes of action. J Biosci Bioeng 2009,107:475-487\n\nAsano Y, Hiramoto T, Nishino R, Aiba Y, Kimura T, Yoshihara K, Koga Y, Sudo N Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice, “Am J Physiol Gastrointest Liver Physiol”, 2012, Dec 1, 303 (11): G1288-95. doi: 10.1152/ajpgi.00341.2012. Epub 2012 Oct 11.\n\nAshraf R, Shah NP, Immune system stimulation by probiotic microorganisms, “Crit Rev Food Sci Nutr”, 2014, 54 (7): 938-56. doi: 10.1080/10408398.2011.619671.\n\nAssociations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34: 864–9\n\nAtaee R. Ajdary S. Zarrindast M. et al. (2010). Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line. J Cancer Res Clin Oncol, 136: 1461 - 1469.\n\nAtaie-Jafari A. Larijani B. Alavi Majd H. Tahbaz F. (2009). Cholesterol-lowering Effect of Probiotic Yogurt in Comparison with Ordinary Yogurt in Mildly to Moderately Hypercholesterolemic Subjects. Annals of Nutrition and Metabolism, 54: 22-7.\n\nAtkinson W. Lockhart S. Whorwell P.J. et al. (2006). Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology, 130: 34 - 43.\n\nAudet M.A., Descarries L., Doucet G. (1989) Quantified regional and laminar distribution of the serotonin innervation in the anterior half of the adult cerebral cortex. J. Chem. Neuroanat. 2: 29-44.\n\nAustin M.A. Brunzell J.D. Fitch W.L. Krauss R.M. (1990). Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis, 10:520-530.\n\nAustin M.A. King M.C. Vranizan K.M. and Krauss R.M. (1990). Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation, 82: 495-506.\n\nAvall-Jaaskelainen S, Palva A (2005) Lactobacillus Surface Layers And Their Applications. FEMS microbiol. rev. 29: 511-529;\n\nAvis TJ, Bélanger RR. Specificity and mode of action of the antifungal fatty acid cis-9-heptadecenoic acid produced by Pseudozyma flocculosa. Applied and Environmental Microbiology. 2001;67:956-960;\n\nAvis TJ, Boulanger RR, Bélanger RR. Synthesis and biological characterization of (Z)-9-heptadecanoic and (Z)-6-methyl-9-heptadecanoic acids: fatty acids with antibiotic activity produced by Pseudomonas flocculosa. Journal of Chemical Ecology.2000;26:987-1000;\n\nAvis TJ. Antifungal compounds that target fungal membrane: application in plant disease control. Canadian Journal of Plant Pathology. 2007; 29:323-329;\n\nAxling, U., Olsson, C., Xu, J., Fernandez, C., Larsson, S., Strom, et al. (2012). Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutrition & Metabolism,9, 105.2012\n\nAzmitia E.C. (1992) Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res. 572: 57-63.\n\nAzmitiaE.C., Buchan A.M., Willis J.H. (1978) Structural and functional restoration by collateral sprouting of hippocampal 5-HT axons. Nature (L) 274: 374-377.\n\nB Kaur et al. 2013 - Biomedical Applications of Fermenticin HV6b Isolated from Lactobacillus fermentum. BioMed Research International Vol 2013\n\nB. Garland (2004). Neuroscience and the Law, New York, Dana Press.\n\nBab I.A. Yirmiya R. (2010). Depression and bone mass. Ann NY Acad Sci, 1192: 170-175.\n\nBaba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M (2009) Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. Immunology 128: e523–31;\n\nBadgaiyan RD, Imaging dopamine neurotransmission in live human brain, “Prog Brain Res”, 2014, 211: 165-82. doi: 10.1016/B978-0-444-63425-2.00007-6.\n\nBae J-M, Yang Y-J, Li Z-M, Ahn Y-O. Low cholesterol is associated with mortality from cardiovascular diseases: a dynamic cohort study in Korean adults. J Korean Med Sci 2002;27;58-63.\n\nBaez S, Gordon HA. Tone and reactivity of vascular smooth muscle in germfree rat mesentery. J Exp Med 134: 846 - 856, 1971.\n\nBaggetto, L. G.; Clottes, E.; Vial, C. Low mitochondrial proton leak due to high membrane cholesterol content and cytosolic creatine kinase as two features of the deviant bioenergetics of Ehrlich and AS30-D tumor cells. Cancer Res. 52: 4935–4941; 1992;\n\nBahrami, B., S. Macfarlane, and G. T. Macfarlane. 2011. Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. J. Appl. Microbiol. 110:353–363\n\nBaigent C. Blackwell L. Emberson J. Holland LE. Reith C. Bhala N. Peto R, Barnes E.H. Keech A. Simes J. Collins R. (2010). Efficacy and Safety of More Intensive Lowering of LDL Cholesterol: A Meta-Analysis of Data from 170,000 Participants in 26 Randomised Trials. Cholesterol Treatment Trialists' (CTT) Collaboration. Lancet, 13: 1670-81.\n\nBailey, M. T. et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 25, 397 - 407 (2011).\n\nBakri MM, Brown DJ, Butcher JP, et al. Clostridium difficile in ready-to-eat salads, Scotland. Emerg Infect Dis 2009; 15 (5):817–8\n\nBakshi A, Stephen S, Borum ML, Doman DB. Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet. Gastroenterol Hepatol (N Y). 2012 Sep;8(9):582-8.\n\nBalamurugan R, Janardhan HP, George S, Raghava MV, Muliyil J, Ramakrishna BS. Molecular studies of fecal anaerobic commensal bacteria in acute diarrhea in children. J Pediatr Gastroenterol Nutr 46: 514 - 519, 2008.\n\nBaldessarini R.J. in \"The Pharmacological Basis of Therapeutics\" 9th Ed. (J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, Eds.) McGraw-Hill, New York, 1996.\n\nBalzan S, de Almeida Quadros C, de Cleva R, et al. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroen Hepatol 2007; 22: 464–71\n\nBammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Impairment of small intestinal protein assimilation in patients with end - stage renal disease: extending the malnutrition - inflammation - atherosclerosis concept. Am J Clin Nutr 2004; 80: 1536– 1543.\n\nBammens B, Verbeke K, Vanrenterghem Y, Evenepoel P: Evidence for impaired assimilation of protein in chronic renal failure. Kidney Int 2003; 64: 2196–2203.\n\nBarbara G. Stanghellini V. De Giorgio R. et al. (2004). Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology, 126: 693-702.\n\nBarczyk M, Debek W, Chyczewski L (1995). Mast cells in the gastrointestinal tract. Rocz Akad Med Bialymst. 40: 26-57;\n\nBarman M, Unold D, Shifley K, Amir E, Hung K, Bos N, Salzman N. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 76: 907 - 915, 2008.\n\nBarradas M.A. Christofides J.A. Jeremy J.Y. Mikhailidis D.P. Fry D.E. Dandona P. (1990). The Effect of Olive Oil Supplementation on Human Platelet Function, Serum Cholesterol-Related Variables and Plasma Fibrinogen Concentrations: A Pilot Study, Nutrition Research. 10: 403-411.\n\nBarrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C, γ-Aminobutyric acid production by culturable bacteria from the human intestine, “J Appl Microbiol”, 2012, Aug, 113 (2): 411-17. doi: 10.1111/j.1365-2672.2012.05344.x. Epub 2012 Jun 15.\n\nBarrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113:411–417.\n\nBarrett, E. et al. Aminobuyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 113, 411 - 417 (2012).\n\nBarros SP, Williams R, Offenbacher S, Morelli T, Gingival crevicular fluid as a source of biomarkers for periodontitis, “Periodontol”, 2016, Feb, 70 (1): 53-64. doi: 10.1111/prd.12107.\n\nBarry Sears, William Lawren: The zone, Harper Collins Publisher (1995)\n\nBartlett, J.G. 2008. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin. Infect. Dis. 46 Suppl 1: S4-11\n\nBartoli R. Fernàndez-Banares F. Navarro E. Castella E. Mane J. Alvarez M. et al. (2000). Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E2 synthesis. Gut. 46: 191-9.\n\nBarzanti V. Battino M. Baracca A. Cavazzoni M. Cocchi M. Noble R. Maranesi M. Turchetto E. Lenaz G. (1994). The effect of dietary lipid changes on the fatty acid composition and function of liver, heart and brain mitochondria in the rat at different ages. The British journal of nutrition 71 (2).\n\nBasso B, Giménez F, López C. IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections. Infect DisObstet Gynecol 2005; 13(4): 207–11\n\nBattaglino R. Fu J. Spate U. et al. (2004). Serotonin regulates osteoclast differentiation through its transporter. J Bone Mineral Res, 19: 1420-1430.\n\nBattersby AJ, Gibbons DL, The gut mucosal immune system in the neonatal period, “Pediatr Allergy Immunol”, 2013, Aug, 24 (5): 414-21. doi: 10.1111/pai.12079. Epub 2013 May 19.\n\nBauer MP, Veenendaal D, Verhoef L, et al. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect 2009;15(12):1087–92;\n\nBauer T.M.et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.Am J Gastroenterol, 2001, 96: 2962-7.\n\nBaumgart D.C. Carding S.R. ( 2007). Inflammatory bowel disease, cause and immunobiology. Lancet, 369: 1627 -1640.\n\nBautista D. Obrador A. Moreno V. Cabeza E. Canet R. Benito E. et al. (1997). Ki-Ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev. 6: 57-61.\n\nBazan N.G. Birkle D.L. Tang W. & Reddy T.S. (1986). in Advances in Neurology, eds. Delgado-Escueta, A. V., Ward, A. A., Woodbury, D. M. & Porter, R. J. (Raven, New York), pp. 879-902.\n\nBeasley, S. S., Saris, P. E. J., Nisin-producing Lactococcus lactis strains isolated from human milk. Journal of Applied and Environmental Microbiology 2004, 70, 5051-5053\n\nBeattie D.T. Smith J.A. (2008). Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol, 377: 181 - 203.\n\nBeauchamp E, Rioux V, Legrand P, New regulatory and signal functions for myristic acid, “Med Sci (Paris)”, 2009, Jan, 25 (1): 57-63. doi: 10.1051/medsci/200925157.\n\nBeaugé F. Gallay J. Stibler H. and Borg S. (1988). Alcohol abuse increases the lipid structural order in human erythrocyte membranes. Biochemical Pharmacology. 37: 3823 - 3828.\n\nBeaugé F. Stibler H. and Borg S. (1985). Abnormal fluidity and surface carbohydrate content of the erythrocyte membrane in alcoholic patients. Alcoholism: Clinical and Experimental Research. 9: 322 - 326.\n\nBeaugerie L, Flahault A, Barbut F, et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003; 17(7):905–12\n\nBeaulieu JM, Espinoza S, Gainetdinov RR, Dopamine receptors - IUPHAR Review 13, “Br J Pharmacol”, 2015, Jan, 172 (1): 1-23.\n\nBekoff M. Allen C. Burghardt GM. (2002). The Cognitive Animal: Empirical and Theoretical Perspectives on Animal Cognition, MIT Press, Cambridge MA.\n\nBekoff M. Pierce J. (2009). Wild Justice: The Moral Lives of Animals, Chicago University Press, Chicago 2009; tr. it.\n\nBelitz H-D, Grosch W, Schieberle P. (1987). Food Chemistry. Springer Verlag Ed., Berlin, Heidelberg, New York, London, Paris, Tokyo, p.175\n\nBell DS, Changes seen in gut bacteria content and distribution with obesity: causation or association?, “Postgrad Med”, 2015, Nov, 127 (8): 863-8. doi: 10.1080/00325481.2015.1098519. Epub 2015 Oct 16.\n\nBellavia M. Damiano G. Gioviale M.C. et al. 2011. Abnormal expansion of segmented filamentous bacteria in the gut, a role in pathogenesis of chronic inflammatory intestinal diseases? Rev. Med. Microbiol, 22: 45 - 47.\n\nBellini M. Rappelli L. Blandizzi C. et al. (2003). Platelet Serotonin Transporter in Patients with Diarrhea-Predominant Irritable Bowel Syndrome both before and after treatment with Alosetron. Am J Gastroenterol, 98: 2705-2711.\n\nBellomo G. Mangiagli A. Nicastro L.. Frigerio G. A controlled double-blind study of SF68 strain as a new biological preparation for the treatment of diarrhea in pediatrics. Curr. Ther. Res, 1980, 28: 927-936.\n\nBenedetti S. Bucciarelli S. Canestrari F. Catalani S. Colomba M. S. Gregorini A. Mandolini S. Marconi V. Mastrogiacomo A. R. Rasenick M. Silvestri R. Tagliamonte M. C. Tonello L. Venanzini R. and Cocchi M. (2012). Molecular Changes in Mood Disorders Results of the Marche Region Special Project. NeuroQuantology, 10: S1-28.\n\nBenedetti, S. , Bucciarelli, S. , Canestrari, F. , Catalani, S. , Mandolini, S. , Marconi, V. , Mastrogiacomo, A. , Silvestri, R. , Tagliamonte, M. , Venanzini, R. , Caramia, G. , Gabrielli, F. , Tonello, L. and Cocchi, M. (2014) Platelet’s Fatty Acids and Differential Diagnosis of Major Depression and Bipolar Disorder through the Use of an Unsupervised Competitive-Learning Network Algorithm (SOM). Open Journal of Depression, 3, 52-73;\n\nBenedetti, S. et al. (2014) Platelet's Fatty Acids and Differential Diagnosis of Major Depression and Bipolar Disorder through the Use of an Unsupervised Competitive-Learning Network Algorithm (SOM). Open Journal of Depression 3: 52-73.\n\nBenedict RF. (1934). Patterns of Cultures, New American Library, New York.\n\nBenedikter R, Giordano J. (2012). Neurotechnology: New frontiers for European policy. Pan Euro Network Sci Tech.3: 204-207.\n\nBenoist, C., Mathis, D., 2002. Mast cells in autoimmune disease. Nature 420, 875– 878; Woolley, D.E., 1995. Mast cells in the rheumatoid lesion—ringleaders or innocent bystanders. Ann. Rheum. Dis. 54, 533–534\n\nBentivoglio M. et al. Anatomia Umana e Istologia. Edizioni Minerva Medica, 2010.\n\nBentley R, Meganathan R: Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol Rev 46: 241–280, 1982.\n\nBenyagoub M, Willemot C, Bélanger RR. Influence of a subinhibitory dose of antifungal fatty acids from Sporothrix flocculosa on cellular lipid composition in fungi. Lipids. 1996;17:1077-1082;\n\nBenyon, R., Robinson, C., Church, M.K., 1989. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br. J. Pharmacol. 97, 898–904;\n\nBercik, P. et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141, 599 - 609 (2011).\n\nBerg, J. M.; Tymoczko, J. L.; Stryer, L. Biochemistry. Freeman, New York; 2007\n\nBergmann KR, Liu SX, Tian R, Kushnir A, Turner JR, Li HL, Chou PM, Weber CR, De Plaen IG, Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis, “Am J Pathol”, 2013, May, 182 (5): 1595-606. doi: 10.1016/j.ajpath.2013.01.013. Epub 2013 Mar 5.\n\nBergren, D. R.; Beckman, D. L. Hyperbaric oxygen and pulmonary surface tension. Aviat. Space Environ. Med. 46:994–995; 1975\n\nBerliner J.A. Heinecke J.W. (1990). The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med 1996, 20: 707-27.\n\nBerman S.M. Chang L. Suyenobu B. et al. (2002). Condition-specifi c deactivation of brain regions by 5-HT3 receptor antagonist alosetron. Gastroenterology, 123: 969 - 977.\n\nBerneis K. Rizzo M. (2004). LDL size: does it matter? Swiss Med Weekly, 134: 720 - 724.\n\nBerneis K.K. Krauss R.M. (2002). Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res, 43: 1363-1379.\n\nBernroider G. Summhammer J. (2012). Can Quantum Entanglement Between Ion Transition States Effect Action Potential Initiation? Cognitive Computation, 4: 29-37.\n\nBernroider, G., Roy, S. (2004) Quantum-Classical Correspondence in the Brain: Scaling, Action Distances and Predictability behind Neural Signals. Forma, 19, 55-68.\n\nBernroider, G., Roy, S. (2005) Quantum entanglement of K+ ions, multiple channel states, and the role of noise in the brain. SPIE, Vol 5841-29.\n\nBerrino F, Il cibo dell'uomo. La via della salute tra conoscenza scientifica e antiche saggezze, Franco Angeli, Milano, 2015-2016. https://books.google.it/books?isbn=8891707449.\n\nBertazzoni E, Donelli G, Midtvedt T, Nicoli J, Sanz Y, Probiotics and clinical effects: is the number what counts?, “J Chemother”, 2013, Aug, 25 (4): 193-212. doi: 10.1179/1973947813Y.0000000078.\n\nBertolami M.C. Faludi A.A. and Batlouni M. (1999). Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercho-lesterolemia. Eur. J. Clin. Nutr, 53: 97 - 101.\n\nBest EL, Fawley WN, Parnell P, et al. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis 2010;50(11):1450–7;\n\nBhat AR, Irorere VU, Bartlett T, Hill D, Kedia G, Charalampopoulos D, Nualkaekul S, Radecka I, Improving survival of probiotic bacteria using bacterial poly-γ-glutamic acid, “Int J Food Microbiol” 2015, Mar 2, 196: 24-31. doi: 10.1016/j.ijfoodmicro.2014.11.031. Epub 2014 Dec 5.\n\nBienenstock J, Kunze W, Forsythe P, Microbiota and the gut-brain axis, “Nutr Rev”, 2015, Aug, 73 Suppl 1: 28-31. doi: 10.1093/nutrit/nuv019.\n\nBienenstock, J., et al. Comparative aspects of mast cell heterogeneity in different species and sites. International archives of allergy and applied immunology 77, 126-129 (1985).\n\nBierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 2003;100:1920 - 1925.\n\nBigatello L.M. Broitman S.A. Fattori L. Di Paoli M. Pontello M. Bevilacqua G. Nespoli A. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol. 82: 11 - 15, 1987.\n\nBiller JA, Katz AJ, Flores AF, et al. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr. 1995; 21:224–226\n\nBinnendijk KH, Rijkers GT, What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics, “Benef Microbes”, 2013, Sep, 4 (3): 223-30. doi: 10.3920/BM2013.0019.\n\nBischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, Maschek H, Stolte M, Gebel M, Manns MP (1996). Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 28: 1-13;\n\nBischoff, S.C. Role of mast cells in allergic and non- allergic immune responses: comparison of human and murine data. Nature reviews. Immunology 7, 93-104 (2007).\n\nBisson J.F. Hidalgo S. Rozan P. Messaoudi M. Preventive effects of different probiotic formulations on travelers' diarrhea model in wistar rats: preventive effects of probiotics on TD. Dig Dis Sci, 2010, 55: 911-919.\n\nBjarnason I. Peters .TJ. Wise R.J.(1984). The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet; 1: 179-182.\n\nBjarnsholt T, Givskov M, The role of quorum sensing in the pathogenicity of the cunning aggressor Pseudomonas aeruginosa, “Annal Bioanal Chem”, 2007, Jan, 387 (2): 409-14. Epub 2006 Sep 26.\n\nBjornheden T. Babyi A. Bondjers G. Wiklund O. (1996). Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis, 123: 43-56.\n\nBlaha M.J. Nasir K. Blumenthal R.S. (2012). Statin Therapy of Healthy Men identified as \"Increased Risk\". Journal of the American Medical Association, 307: 1489-90.\n\nBlaschke-Hellmessen R. Habitats for Candida in medical and hygienic respects. Mycoses. 1999; 42(Suppl. 1):22 - 29; Odds FC. Ecology and epidemiology of Candida species. Zentralbl. Bakteriol. Mikrobiol. Hyg. 1984; A 257:207 - 212.\n\nBloch, K. E. Evolutionary perfection of a small molecule. Blondes in Venetian paintings, the nine-banded armadillo, and other essays in biochemistry, Chap. 2. Yale University Press, New Haven, pp. 14–36; 1994\n\nBloom, M.; Mouritsen, O. G. The evolution of membranes. Can. J. Chem.-Rev. Can. Chim. 66:706–712; 1988\n\nBode C. Bode J.C. (2003). Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol. 17: 575-592.\n\nBode C. Bode J.C. (2005). Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin Exp Res; 29: 166S-171S.\n\nBode J.C. Bode C.(1984). Heidelbach R. Durr H.K. Martini G.A. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology. 31: 30-34.\n\nBohmig GA, Krieger PM, Saemann MD, et al. n-butyrate down regulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids. Immunology 1997;92:234 - 43.\n\nBoikov S.S. Moroz A.F. Babaeva E.E. Association of Candida albicans fungi with some opportunistic microorganisms intestinal dysbiosis in patients of different age groups. Zh Mikrobiol Epidemiol Immunobiol, 2005, 2: 65-9.\n\nBone E, Tamm A, Hill M: The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr 1976; 29: 1448–1454.\n\nBongetta et al, 1981: The colonization od S. faecium in human intestinal tract after oral administration. Boll. Ist. Sieroter. Milanese 60: 381-385. Friis-Moller, Alice, Henrik Hey, 1983 Colonization of the intestinal canalwith a faecium preparation. Curr. Ther. Res. 33 (5) May\n\nBoniotto M, Jordan WJ, Eskdale J, Tossi A, Antcheva N, Crovella S, et al. Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother 2006; 50(4): 1433–41.\n\nBorchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME, Probiotics and immunity, “J Gastroenterol”, 2009, 44 (1): 26-46. doi: 10.1007/s00535-008-2296-0. Epub 2009 Jan 22.\n\nBorland LM, Michael AC. Voltammetric study of the control of striatal dopamine release by glutamate. J Neurochem 2004;91:220 - 229.\n\nBoshuizen JA. Et al. 2003. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. Journal of virology 77: 13005-13016.\n\nBossola M, Sanguinetti M, Scribano D et al. Circulating bacterial - derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin J Am Soc Nephrol 2009; 4: 379–385.\n\nBoullin D.J. O'Brien D.R. (1971). Abnormalities of 5- Hydroxytryptamine Uptake and Binding by Blood Platelets from Children with Down's syndrome. J Physiol, 212: 287 - 297.\n\nBourre J.M, Piciolti M. Dumont O. Pascal G. and Durand G. (1990) Dietary Linoleic Acid and Polyunsaturated Fatty Acids in Rat Brain and Other Organs. Minimal Requirements of Linoleic Acid. LIPIDS 25 (8).\n\nBouskra D, Brezillon C, Berard M, Werts C, Varona R, Boneca IG, Eberl G. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456: 507 - 510, 2008.\n\nBouwknecht J.A. van der Gugten J. Hijzen T.H. et al. (2001). Male and female 5-HT1B receptor knockout mice have higher body weights than wildtypes. Physiol Behav, 74: 507 - 516.\n\nBowe WP and Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? Gut Pathogens 2011, 3:1\n\nBower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002;64:604 - 611.\n\nBowker R.M., Abbott L.C. (1990) Quantitative re-evaluation of descending serotonergic and nonserotonergic projections from the medulla of the rodent: evidence for extensive co-existence of serotonin and peptides in the same spinally projecting neurons, but not from the nucleus raphe magnus. Brain Res. 5 12: 15-25.\n\nBoyle Robert J, Robins-Browne R, Tang Mimi LK. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006; 83: 1256-1264;\n\nBradshaw, J. (2011) Dog Sense. How the New Science of Dog Behavior Can Make You a Better Friend.New York: Basic Books.\n\nBrady L.J. Gallaher D.D. and Busta F.F. The role of probiotic cultures in the prevention of colon cancer. J. Nutr, 2000,130(Suppl. 2): 410-414.\n\nBrain of the lamprey, Lampetrafluviatilis: an evolutionary perspective. J. Chem. Neuroanat. 5: 195-219.\n\nBranch-Mays GL, Dawson DR, Gunsolley JC, et al. The effects of a calorie-reduced diet on periodontal inflammation and disease in a nonhuman primate model. J Periodontol 2008;79(7): 1184-1191;\n\nBrand S. (2009). Crohn's disease, Th1, Th17 or both? The change of a paradigm, new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut, 58: 1152-1167.\n\nBrandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005;100(Suppl 1):S5-212.\n\nBrandvold KR, Morimoto RI, The Chemical Biology of Molecular Chaperones-Implications for Modulation of Proteostasis, “J Mol Biol”, 2015, Sep 11, 427 (18): 2931-47. doi: 10.1016/j.jmb.2015.05.010. Epub 2015 May 21.\n\nBranen AL, Davidson PM, Katz B. Antibacterial properties of phenolic antioxidants and lipids. Food Technoogy. 1980;34:42-63;\n\nBraude A.I. Carey F.J. Zalesky M. (1955). Studies with radioactive endotoxin. II. Correlation of physiologic effects with distribution of radioactivity in rabbits injected with radioactive sodium chromate. J Clin Invest. 34: 858-866.\n\nBraun S. (1996). Buzz: The Science and Law of Alcohol and Caffeine. Oxford University. Press: New York, USA.\n\nBravo J.A. Forsythe P. Chew M.V. Escaravage E. Savignac H.M. Dinan T.G. Bienenstock J. Cryan J.F. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 108: 16050-5.\n\nBrenchley J.M. Price D.A. Schacker T.W. et al. (2006). Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 12: 1365-1371.\n\nBrenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371;\n\nBrenner SA, Zacheja S, Schäffer M, Feilhauer K, Bischoff SC, Lorentz A, Soluble CD14 is essential for lipopolysaccharide-dependent activation of human intestinal mast cells from macroscopically normal as well as Crohn's disease tissue, “Immunology”, 2014, Oct, 143 (2): 174-83. doi: 10.1111/imm.12299.\n\nBrightling, C.E., Bradding, P.,Symon, F.A., Holgate, S.T., Wardlaw, A.J., Pavord, I.D.,2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med.346,1699–1705;\n\nBritish Heart Foundation. Trends in coronary heart disease, 1961-2011. 2011. www.bhf. org.uk/publications/view-publication.aspx?ps=1001933.\n\nBrodie B.B., Shore P.A. (1957) A concept for the role of serotonin and norepinephrine as chemical mediators in the brain. Ann. N.Y. Acad. Sci. 66: 631-642.\n\nBroitman S.A. Gottlieb L.S. Zamcheck N. (1964). Influence of neomycin and ingested endotoxin in the pathogenesis of choline deficiency cirrhosis in the adult rat. J Exp Med. 119: 633-642.\n\nBrooks PJ, Zakhari S, Acetaldehyde and the genome: beyond nuclear DNA adducts and carcinogenesis, “Environ Mol Mutagen”, 2014, Mar, 55 (2): 77-91. doi: 10.1002/em.21824. Epub 2013 Nov 27.\n\nBrosnan CF, Claudio L, Tansey FA, Martiney J (1990) Mechanisms of autoimmune neuropathies. Ann Neurol 27: S75–79;\n\nBrotman RM, Ravel J, Cone RA, Zenilman JM. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect 2010; 86: 297–302\n\nBrown J, Wilson T, Metcalfe D (2008). The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin and Exp Allergy 38:4-18;\n\nBrown MA, Hatfield JK: Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy? Front Immunol, 2012; 3: 147;\n\nBrown MS, Goldstein JL (1974) Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7- ketocholesterol. J Biol Chem 249: 7306–7314\n\nBrown RE, Stevens DR, Haas HL (2001) The physiology of brain histamine. Prog Neurobiol 63:637–672.\n\nBrown, G. D. et al. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 2003; 197, 1119 - 1124;\n\nBrown, J.M., Wilson, T.M. & Metcalfe, D.D. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 38, 4-18 (2008).\n\nBruckert E. Hayem G. Dejager S. Yau C. Begaud B. (2005). Mild to moderate muscular symptoms with high dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther, 19: 403 - 14.\n\nBruckner G. (2000). Fatty acids and cardiovascular disease. \"Fatty acids in foods and their health implications\". Chow editor, Marcel Dekker New York, Basel, 843-63.\n\nBrumfitt W, Salton MRJ, Hamilton-Miller JMT (2002) Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J Antimicrob Chemother 50:31–734\n\nBrunetti L, et al. Surveillance of nosocomial infections: a preliminary study on yeast carriage on hands of healthcare workers. J. Prev. Med. Hyg. 2008; 49:63 - 68\n\nBrydon L, Harrison NA, Walker C, Steptoe A, Critchley HD. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 2008;63:1022 - 1029.\n\nBuchwald, H.; O'Dea, T. J.; Menchaca, H. J.; Michalek, V. N.; Rohde, T. D. Effect of plasma cholesterol on red blood cell oxygen transport. Clin. Exp. Pharmacol. Physiol. 27:951–955; 2000\n\nBuckley MG, Coleman JW (1992). Cycloheximide treatment of mouse mast cells inhibits serotonin release. Biochem Pharmacol. 44: 659-664;\n\nBueno L, Fioramonti J (1999). Effects of inflammatory mediators on gut sensitivity. Can J Gastroenterol. 13: 42A-46A;\n\nBull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C, et al. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry. 2008.\n\nBullock C. (1990). The Biochemistry of Alcohol Metabolism. Biochemical Education, 18(2).\n\nBurger LY, Martin-Iverson MT, Increased occupation of D1 and D2 dopamine receptors accompanies cocaine-induced behavioral sensitization, “Brain Res”, 1994, Mar 14; 639 (2): 228-32.\n\nBurmeister KK. Shedden MK Sen S. (2011). The Serotonin Transporter Promoter Variant (5- HTTLPR), Stress, and Depression Meta-analysis Revisited. Arch Gen Psychiatry, 68(5):444-54\n\nBurns A.J. Rowland I.R. Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol, 2000, 1: 13-24.\n\nBurokas A, Moloney RD, Dinan TG, Cryan JF, Microbiota regulation of the Mammalian gut-brain axis, “Adv Appl Microbiol”, 2015, 91: 1-62. doi: 10.1016/bs.aambs.2015.02.001. Epub 2015 Mar 11.\n\nButzner JD, Parmar R, Bell CJ, et al. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 1996;38:568 - 73.\n\nBuznikov G.A., Shmukler Y.B. (1981) Possible role of \"prenervous\" neurotransmitters in cellular interactions of early embryogenesis: a hypothesis. Neurochemical Res. 6: 55-68.\n\nCabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A, The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery, “Am J Clin Nutr”, 2012, Sep, 96 (3): 544-51. doi: 10.3945/ajcn.112.037382. Epub 2012 Jul 25.\n\nCachofeiro V, Goicochea M, de Vinuesa SG et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 2008; 111: S4–S9.\n\nCalanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, Vilsbøll T, Knop FK, Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies, “Diabetologia”, 2013, May, 56 (5): 965-72. doi: 10.1007/s00125-013-2841-0. Epub 2013 Feb 3.\n\nCalderwood SK, Khaleque MA, Sawyer DB, Ciocca DR, Heat shock proteins in cancer: chaperones of tumorigenesis, “Trends Biochem Sci”, 2006, Mar, 31 (3): 164-72. Epub 2006 Feb 17.\n\nCallanan M, Kaleta P, O’Callaghan J, O’Sullivan O, Jordan K, McAuliffe O, et al., Genome sequence of Lactobacillus helveticus, an organism distinguished by selective gene loss and insertion sequence element expansion, “J Bacteriol” [Internet], 2008, Jan [cited 2015 Sep 16], 190 (2): 727-35.\n\nCamacho A. Dimsdale J.E. (2000). Platelets and Psychiatry: Lessons Learned from Old and New tudies. Psychosom. Med. 62: 326-336.\n\nCamilleri M. Chey W.Y. Mayer E.A. et al. (2001). A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med, 161: 1733 - 1740.\n\nCamilleri M. Lee J.S. Viramontes B. et al. Insights into pathophysiology and mechanisms of constipation, IBS and diverticulosis in older people. J Am Geriatr Soc, 2000, 48: 1142 - 50.\n\nCampanella C. Bucchieri F, Merendino AM, Fucarino A, Burgio G, Corona DF, Barbieri G, David S, Farina F, Zummo G, de Macario EC, Macario AJ, Cappello F. (2012). The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLoS One, 7 (7): e42008.\n\nCampbell AK, Waud JP, Matthews SB. The molecular basis of lactose intolerance. Sci Prog. 2005;88(Pt 3):157-202.\n\nCani P.D et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia, 2007, 50: 2374-83.\n\nCani P.D. Bibiloni R. Knauf C. et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet - induced obesity and diabetes in mice. Diabetes, 57: 1470-1481.\n\nCani P.D. Delzenne N.M. (2009). The role of the gut microbiota inenergy metabolism and metabolic disease. Curr Pharm Des. 15: 1546-1558.\n\nCani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56(7):1761-1772;\n\nCani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470–81;\n\nCani PD, Osto M, Geurts L, et al. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012; 3::279–88\n\nCapella P., Caboni M.F., Bonaga G., Lercker G. (1988). Meccanismi di formazione dei prodotti di evoluzione degli idroperossidi monoinsaturi: idrossi- e cheto- esteri. Riv. Ital. Sostanze Grasse, 65, 629-31.\n\nCaporaso JG, Lauber CL, Costello EK, et al. Moving pictures of the human microbiome. Genome Biol 2011; 12: R50;\n\nCappello F, Marino Gammazza A, Palumbo Piccionello A, Campanella C, Pace A, Conway de Macario E, Macario AJL. Hsp60 chaperonopathies and chaperonotherapy: targets and agents. Expert\n\nCappello F. Bellafiore M. Palma A. David S. Marciano V. Bartolotta T. Sciume C. Modica G. Farina F. Zummo G. Bucchieri F. 60KDa chaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur J Histochem, 2003, 47: 105-10.\n\nCappello F. David S. Peri G. Farina F. Conway de Macario E. Macario A.J. Zummo G. Hsp60: molecular anatomy and role in colorectal cancer diagnosis and treatment. Front Biosci (Schol Ed), 2011,, 3: 341-51.\n\nCappello F. David S. Rappa F. Bucchieri F. Marasa L. Bartolotta T.E. Farina F. Zummo G. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastases. BMC Cancer, 2005, 5: 139.\n\nCappello F. et al. Cchaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur J Histochem, 2003, 47: 105-10.\n\nCappello F. et al. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer, 2005, 5, 139.\n\nCapuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al. Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002;26:643 - 652.\n\nCapuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, et al. Interferon alphainduced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment. Biol Psychiatry 2003;54:906 - 914.\n\nCarabotti M, Scirocco A, Maselli MA, Severi C, The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems, “Ann Gastroenterol”, 2015, Apr-Jun, 28 (2): 203-09.\n\nCaradonna L. Mastronardi M.L. Magrone T. et al. (2002). Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr Pharm Des; 8: 995-1005.\n\nCarballeira NM, O'Neil R, Parang K. Racemic and optically active 2-methoxy-4-oxatetradecanoic acids: novel synthetic fatty acids with selective antifungal properties. Chemistry and Physics of Lipids. 2005;136:47-54.\n\nCardenia V, Vivarelli F, Canistro D, Estrada MTR. Linoleic acid in brain rat and obesity disease: a new starting point for chronic disease? Commun Ital Soc Exp Biol (Sect Bologna). 2015 (Data not published).\n\nCario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132: 1359 - 1374, 2007.\n\nCario E. Brown D. McKee M. et al. (2002). Commensal associated molecular patterns induce selective toll-like receptortrafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol, 160: 165 - 173.\n\nCarroll J, Draper LA, O’Connor PM, Coffey A, Hill C, Ross RP, Cotter PD, O’Mahony J (2010) Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria. Int J Antimicrob Agents 36:132–136\n\nCasadesu´ s J. Bacterial L-forms require peptidoglycan synthesis for cell division. Bioessays 2007; 29: 1189–91\n\nCasari E, Ferrario A, Morenghi E, Montanelli A. Gardnerella, trichomonas vaginalis, candida, Chlamydia trichomatis, mycoplasma hominis and ureaplasma urealyticum in the genital discharge of symptomatic fertile and asymptomatic infertile women. New Microbiologica 2010; 33: 69-76\n\nCasey C.A. Nanji A. Cederbaum A.I. Adachi M. Takahashi T. (2001). Alcoholic liver disease and apoptosis. Alcohol Clin Exp Res. 25: 49S-53S\n\nCash H.L. Whitham C.V. Behrendt C.L. Hooper L.V. (2006). Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science, 313: 1126 - 1130.\n\nCastagliuolo I, LaMont JT, Nikulasson ST, Pothoulakis C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun 1996; 64: 5225-5232 [PMID: 8945570]\n\nCatalogo NU-CHEK Prep., Inc. (2011-2012). P.O. Box 295; 109 West Main St., Elysian, MN 56028 U.S.A.\n\nCauci S, Guaschino S, De Aloysio D, Driussi S, De Santo D, Penacchioni P, et al. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 2003; 9(1): 53–8.\n\nCauci S, Guaschino S, Driussi S, De Santo D, Lanzafame P, Quadrifoglio F. Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. J Infect Dis 2002; 185(11): 1614–20.\n\nCavera VL, Arthur TD, Kashtanov D, Chikindas ML, Bacteriocins and their position in the next wave of conventional antibiotics, “Int J Antimicrob Agents”, 2015, Nov, 46 (5): 494-501. doi: 10.1016/j.ijantimicag.2015.07.011.Epub 2015 Aug 22.\n\nCecilia Jernberg et al, Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010.\n\nCedars M (ed). Infertility: practical pathways in obstetrics and gynecology New York: McGraw-Hill; 2005:88-133\n\nCenci-Goga et al. (2016) Effect of a novel starter culture and specific ripening conditions on microbiological characteristics of nitrate-free dry-cured pork sausages. Italian Journal of Animal Science, 15:3, 358-374.\n\nCenci-Goga et al. (2016) Growth Inhibition of Selected Microorganisms by an Association of Dairy Starter Cultures and Probiotics. Italian Journal of Animal Science, 14:2, 3745\n\nCenedella, R. J. Cholesterol and cataracts. Surv. Ophthalmol. 40:320–337; 1996;\n\nCercaci L. Rodriguez-Estrada M.T. Lercker G. Decker E.A. (2007). Phytosterol oxidation in oil-in-water emulsions and bulk oil. Food Chem, 102: 161-7.\n\nCerutti A. Rescigno M. (2008). The biology of intestinal immunoglobulin A responses. Immunity, 28: 740 - 750.\n\nChaban B, Links MG, Jayaprakash TP, Wagner EC, Bourque DK, Lohn Z, et al. Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome 2014; 2: 23\n\nChajes V. Thiebaut A.C. Rotival M. Gauthier E. Maillard V. Boutron-Ruault M.C. et al. (2008). Association between serum trans- monounsaturated fatty acids and breast cancer risk in the E3N- EPIC Study. Am J Epidemiol. 167: 1312-20.\n\nChallacombe D.N. Dawkins P.D. Baker P. (1977). Increased tissue concentrations of 5-hydroxytryptamine in the duodenal mucosa of patients with coeliac disease. Gut, 18: 882 - 886.\n\nChampeau R. Most heart attack patients' cholesterol levels did not indicate cardiac risk. UCLA Newsroom. 2009. http://newsroom.ucla.edu/portal/ucla/majority-of-hospitalizedheart- 75668.aspx.\n\nChang FY, et al. Analysis of the serum levels of fungi-specific immunoglobulin E in patients with allergic diseases. Int. Arch. Allergy Immunol. 2011; 154:49 - 56;\n\nChang Hwa Hwang, Birgit U. Jaki, Larry L. Klein, David C. Lankin, James B. McAlpine, José G. Napolitano, Nicole A. Fryling, Scott G. Franzblau, Sang Hyun Cho, Paul E. Stamets, Yuehong Wang, and Guido F. Pauli. Chlorinated Coumarins from the Polypore Mushroom Fomitopsis officinalis and Their Activity against Mycobacterium tuberculosis. J. Nat. Prod., 2013; 76 (10), pp 1916 - 1922;\n\nChang PV, Hao L, Offermanns S, Medzhitov R, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition, “Proc Natl Acad Sci USA”, 2014, Feb 11, 111 (6): 2247-52. doi: 10.1073/pnas.1322269111. Epub 2014 Jan 3.\n\nChaplin AV, Efimov BA, Smeianov VV, Kafarskaia LI, Pikina AP, Shkoporov AN, Intraspecies Genomic Diversity and Long-Term Persistence of Bifidobacterium longum, “PLoS One”, 2015, Aug 14; 10 (8): e0135658. doi: 10.1371/journal.pone.0135658. eCollection 2015.\n\nChastain G. (2006). Alcohol, Neurotransmitter Systems, and Behaviour. The Journal of General Psychology, 133(4): 329-335.\n\nChaudhry KK, Shukla PK, Mir H, Manda B, Gangwar R, Yadav N, McMullen M, Nagy LE, Rao R, Glutamine supplementation attenuates ethanol-induced disruption of apical junctional complexes in colonic epithelium and ameliorates gut barrier dysfunction and fatty liver in mice, “J Nutr Biochem ”, 2016, Jan, 27: 16-26. doi: 10.1016/j.jnutbio.2015.08.012. Epub 2015 Aug 20.\n\nChen C, Grimbaldeston M, Tsai M, Weissman I, Galli S (2005). Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A 102:11408-11413\n\nChen H,Hoover DG: Bacteriocins and their food applications. Compr Rev Food Sci F 2003, 2:82-100;\n\nChen HW, Heiniger HJ, Kandutsch AA (1975) Relationship between sterol synthesis and DNA synthesis in phytohemagglutinin-stimulated mouse lymphocytes. Proc Natl Acad Sci USA 72: 1950–1954;\n\nChen HW, Kandutsch AA, Waymouth C (1974) Inhibition of cell growth by oxygenated derivatives of cholesterol. Nature 251: 419–421;\n\nChen J.J. Li Z.S. Pan H. et al. (2001). Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the highaffinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J Neurosci, 21: 6348 - 6361.\n\nChen M, Yu L, Liu Q, Jiang H, Zhou S, Vagus nerve stimulation: A spear role or a shield role in atrial fibrillation?, “Int J Cardiol”, 2015, Nov 1, 198: 115-16. doi: 10.1016/j.ijcard.2015.06.171. Epub 2015 Jul 5.\n\nChen W. Gluud C. Bile acids for liver-transplanted patients. Cochrane Database Syst Rev, 2005, 20: CD005442. Epub PMID: 16034975\n\nChen X, Kokkotou EG, Mustafa N, Bhaskar KR, Sougioultzis S, O’Brien M, Pothoulakis C, Kelly CP. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. J Biol Chem 2006; 281: 24449-24454 [PMID:16816386]\n\nChen Y, Chen Z, Guo R, Chen N, Lu H, Huang S, Wang J, Li L: Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection. Diagn Micr Infec Dis 2011, 70:492-498;\n\nChen Y. Yang F. Lu H. Wang B. Chen Y. Lei D. Wang Y. Zhu B. Li L. (2011). Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 54: 562 - 572.\n\nCheng MY, Hartl FU, Horwich AL. The mitochondrial chaperonin hsp60 is required for its own assembly. Nature. 19909; 348(6300):455-8.\n\nCherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37: 319–25.\n\nChick J. Erickson C.K. (1996). Conference summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in Its Treatment. Alcohol Clin Exp Res. 20:391-402.\n\nChifflet S. and Hernandez J.A. (2011). The Plasma Membrane Potential and the Organization of the Actin Cytoskeleton of Epithelial Cells, International Journal of Cell Biology, Volume 2012 Article ID 121424, 13 pages, doi:10.1155/2012/121424.\n\nCho CH (1994). The role of endogenous ulcerogenic mediators in the pathogenesis of peptic ulcer. Life Sci. 55: 1521-1535;\n\nChoi SS, Kang BY, Chung MJ, Kim SD,Park SH, Kim JS, Kang CY and Ha NJ (2005) Safety Assessment of Potential Lactic Acid Bacteria Bifidobacterium longum SPM1205 Isolated from Healthy Koreans. J. microbiol. 43: 493-498\n\nChojnacka-W6jcikE. (1995) 5-hydroxytryptamine in the central nervous system. Pol. J. Pharmacol. 47: 219- 235.\n\nCholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90.\n\nChoque B, Catheline D, Rioux V, Legrand P, Linoleic acid: between doubts and certainties, “Biochimie”, 2014, Jan, 96: 14-21. doi: 10.1016/j.biochi.2013.07.012. Epub 2013 Jul 27.\n\nChristens R, Schar D, Turner D. An evaluative study of the effectiveness of a strain of Grifola frondosa (maitake) against persistent vaginal Candida albicans proliferation (thrush). Unpublished; posted at planetbotanic.com/ thrushtrial.htm.\n\nChristensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168: 171 - 178, 2002.\n\nChristian EP, Undem BJ, Weinreich D. Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro. J Physiol 1989; 409:297-312;\n\nChung R.W.S. Kamili A. Tandy S. Weir J.M. Gaire R. et al. (2013). Dietary Sphingomyelin Lowers Hepatic Lipid Levels and Inhibits Intestinal Cholesterol Absorption in High-Fat-Fed Mice. PLoS ONE 8(2): e55949. doi:10.1371/journal.pone.0055949.\n\nCianci R. Iacopini F. Petruzziello L et al. Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol 2009; 44: 108 - 115.\n\nCimino M. Gelosa P. Gianella A. Nobili E. Tremoli E. Sironi L. (2007). Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist, 13: 208 - 13.\n\nCindoruk M. ErkanG. KarakanT. DursunA. Unal S. Efficacy and Safety of Saccharomyces boulardii in the 14-day Triple Anti-Helicobacter pylori Therapy: A Prospective Randomized Placebo-Controlled Double-Blind Study. Helicobacter, 2007,12: 309-316.\n\nCintas LM, Casaus P, Herranz C, Havarstein LS, Holo H, Hernandez PE, Nes IF: Biochemical and genetic evidence that Enterococcus faecium L50 produces enterocins L50A and L50B, the sec-dependent enterocin P, and a novel bacteriocin secreted without an N-terminal extension termed enterocin Q. J Bacteriol 2000, 182:6806-6814;\n\nCircu ML, Aw TY, Intestinal redox biology and oxidative stress, “Semin Cell Dev Biol”, 2012, Sep, 23 (7): 729-37. doi: 10.1016/j.semcdb.2012.03.014. Epub 2012 Mar 30.\n\nCitar M, Hacin B, Tompa G, Stempelj M, Rogelj I, Dolinsek J, Narat M, Matijasic BB, Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells, “Benef Microbes”, 2015, 6 (3): 325-6. doi: 10.3920/BM2014.0081.\n\nClaire L. Boulangé et al, Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Medicine 2016.\n\nClapp P. Bhave S.V. and Hoffman, P.L. (2008). How Adaptation of the Brain to Alcohol Leads to Dependence: A Pharmacological Perspective. Alcohol Research and Health, 31(4): 310-340.\n\nClark, J. D. Influence of antibiotics or certain intestinal bacteria on orally administered Candida albicans in germ-free and conventional mice. Infect. Immun. 1971; 4, 731 - 737;\n\nClarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine2,3-dioxygenase activation in a male cohort. BMC Gastroenterol 2009;9:6. (b)\n\nClarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013;18:666 - 73.\n\nClarke G, McKernan DP, Gaszner G, Quigley EM, Cryan JF, Dinan TG. A distinct profile of tryptophan metabolism along the kynurenine pathway downstreamof toll-like receptor activation in irritable bowel syndrome. Front Pharmacol2012;3:90.\n\nClarke G, Quigley EM, Cryan JF, Dinan TG. Irritable bowel syndrome: towards biomarker identification. Trends Mol Med 2009;15:478 - 89. (a)\n\nClarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG, Minireview: Gut microbiota: the neglected endocrine organ, “Mol Endocrinol”, 2014, Aug, 28 (8): 1221-38. doi: 10.1210/me.2014-1108. Epub 2014 Jun 3.\n\nClarke IJ, Hypothalamus as an endocrine organ, “Compr Physio.”, 2015, Jan, 5 (1): 217-53. doi: 10.1002/cphy.c140019.\n\nClarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V. The Q SEC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci USA 103: 10420 - 10425, 2006.\n\nCline JC, Nutritional aspects of detoxification in clinical practice, “Altern Ther Health Med”, 2015, May-Jun, 21 (3): 54-62.\n\nCoates M.D. Mahoney C.R. Linden D.R. Molecular Defects in Mucosal Serotonin Content and Decreased Serotonin Reuptake Transporter in Ulcerative Colitis and Irritable Bowel Syndrome. Gastroenterology, 126: 1657-64.\n\nCocchi et al. BMC Neurosci (2017) 18:38\n\nCocchi et al. Linoleic acid: Is this the key that unlocks the quantum brain? Insights linking broken symmetries in molecular biology, mood disorders and personalistic emergentismBMC Neurosci (2017) 18:38.\n\nCocchi M and TonelloL. (2012). How mathematics can inform the diagnosis of Mood Disorders. NeuroQuantology, 10: S1-28.\n\nCocchi M, Gabrielli F, Tonello L, Pregnolato M. (2010). The Interactome Hypothesis of Depression. NeuroQuantology, 4: 603-613.\n\nCocchi M, Gabrielli F, Tonello L, Pregnolato M. (2011). Consciousness and Hallucinations: Molecular Considerations and Theoretical Questions. NeuroQuantology, 9: 182-189.\n\nCocchi M, Gabrielli F, Tonello L. Platelet's Fatty Acids Secrets in Coronary Artery Disease (CAD), Lett to Ed BMJ. 2013; Oct 28.\n\nCocchi M, Minuto C, Tonello L, Tuszynski JA. Connection between the Linoleic Acid and Psychopathology: A Symmetry- Breaking Phenomenon in the Brain? Open Journal of Depression, 2015, 4, 41-52.\n\nCocchi M, Tonello L and Gabrielli F. (2012). \"Considerations on Blood Platelets: A Neuron's Mirror for Mood Disorders?\" Open Journal of Blood Diseases, Vol. 2 No. 2, 2012, pp. 22-29.\n\nCocchi M, Tonello L, Bosi S, Cremonesi A, Castriota F, Puri B, Tsaluchidu S. Platelet oleic acid as Ischemic Cardiovascular disease marker. BMJ 2004; 329:1447.\n\nCocchi M, Tonello L, Gabrielli F, Pregnolato M. (2011). Biological and Anthropological-Existential Hypothesis on Depression. Quantum Biosystems, 3: 12- 18.\n\nCocchi M, Tonello L, Gabrielli F, Pregnolato M. & Pessa E. (2011). Quantum Human & Animal Consciousness: A Concept Embracing Philosophy, Quantitative Molecular Biology & Mathematics. Journal of Consciousness Exploration & Research, 2: 547-574.\n\nCocchi M, Tonello L, Gabrielli F. \"Platelet, Fatty Acids, Membrane Viscosity, Depression and Ischemic Heart Disease: Biological-Molecular- Path with Medical-Anthropology Insights\" in \"Coronary Angiography-Advances in Noninvasive Imaging Approach for Evaluation of Coronary Artery Disease\", InTech, September 2011, ISBN 978-953-307-675-1.\n\nCocchi M, Tonello L, Lercker G. Fatty acids, membrane viscosity, serotonin and ischemic heart disease. Lipids in Health and Disease, 2010; 9: 97.\n\nCocchi M. et al. Depression, osteoporosis, serotonin and cell membrane viscosity between biology and philosophical anthropology. Annals of General Psychiatry 2011, 10:9.\n\nCocchi M. Gabrielli F. Pessa E. Pregnolato M. Tonello L. Zizzi P. (2012). Major Depression and Bipolar Disorder: The Concept of Symmetry Breaking. NeuroQuantology, 10: 676-687.\n\nCocchi M. Gabrielli F. Tonello L. (2012). Collection of scientific papers in memory of Paolo Sotgiu. The most important scientific publications in the triennium 2009-2011 by The\"Paolo Sotgiu\" Research Institute for Quantitative and Evolutionary Psychiatry and Cardiology, Ludes University Press, Lugano.\n\nCocchi M. Gabrielli F. Tonello L. (2012). The animal side of Mood Disorder, Lambert Publishing.\n\nCocchi M. Lercker G. Gabrielli F. Tonello L. Cappello F. Rizzo M. Gallanter B. (2013). Il colesterolo. Editore Ludes University Press, Lugano, Switzerland.\n\nCocchi M. Mordenti A.L. (2005). Alimenti e Salute, i nutrienti strategici. CLUEB Editore, Bologna.\n\nCocchi M. Sardi L. Tonello L. Martelli G. (2009). Do mood disorders play a role on pig welfare? Ital J Anim Sci 8, 691-704.\n\nCocchi M. Tonello L, “Bio molecular considerations in Major Depression and Ischemic Cardiovascular Disease”. Central Nervous System Agents in Medicinal Chemistry. 9: 2-11. 2010;\n\nCocchi M. Tonello L, Cappello G, Tarozzi G, Nabacino L, Pastorini E, Bucciarelli S, Solazzo L, De Luca M, Visci G, Caramia G. Membrane platelet fatty acids: biochemical characterisation of the ischemic cardiovascular disease, characteristics of the paediatric age, through an Artificial Neural Network interpretation. Ped. Med.Chir. (Med.Surg. Ped.) 2008; 30:25-30.\n\nCocchi M. Tonello L. (2006). \"Biological, Biochemical and Mathematical considerations about the use of an Artificial Neural Network (ANN) for the study of the connection between Platelet Fatty Acids and Major Depression\" J. Biol. Res. LXXXI, 82-87.\n\nCocchi M. Tonello L. (2010). Bio molecular considerations in Major Depression and Ischemic Cardiovascular Disease. Central Nervous System Agents in Medicinal Chemistry.10: 2, 97-107.\n\nCocchi M. Tonello L. (2010a). \"Running the hypothesis of a bio molecular approach to psychiatric disorder characterization and fatty acids therapeutical choices\", Annals of General Psychiatry, 9 (supplement 1): S26.\n\nCocchi M. Tonello L. (2010b). \"Bio molecular considerations in Major Depression and Ischemic Cardiovascular Disease\". Central Nervous System Agents in Medicinal Chemistry, 9: 2-11.\n\nCocchi M. Tonello L. (2011). Ragionando di Nutrizione. Progress in Nutrition. 13, 2.\n\nCocchi M. Tonello L. & Gabrielli F. (2012). Molecular Uniqueness of Major Depression: Biological Remarks and Theoretical Implications. Journal of Consciousness Exploration & Research, 3: 380-391.\n\nCocchi M. Tonello L. & Gabrielli F. (2012). Possible Roles of Cell Membrane & Cytoskeleton in Quantum Aspect of Psychiatry. Journal of Consciousness Exploration & Research, 3: 1082-1100.\n\nCocchi M. Tonello L. Cappello G. (2008). The use of self-organizing maps to study fatty acids in neuropsychiatric disorders. Annals of General Psychiatry, 7(suppl 1):S84.\n\nCocchi M. Tonello L. Cappello G. Tarozzi G. et al. (2008). Membrane platelet fatty acids: biochemical characterisation of the ischemic cardiovascular disease, characteristics of the paediatric age, through an artificial neural network interpretation. Medical and surgical pediatrics. 30(1).\n\nCocchi M. Tonello L. De Lucia A. Amato P. (2009). \"Platelet and Brain Fatty Acids: a model for the classifcation of the animals? Part 1\". International Journal of Anthropology, 24, 69-76.\n\nCocchi M. Tonello L. De Lucia A. Amato P. (2009). Platelet and Brain Fatty Acids: a model for the classification of the animals? Part 2. Platelet and Brain Fatty acid transfer: Hypothesis on Arachidonic Acid and its relationship to Major Depression, International Journal of Anthropology, 24, 69-76.\n\nCocchi M. Tonello L. De Lucia A. Amato P. (2009). Platelet and Brain Fatty Acids: a Model for the Classification of the Animals? Part 2. Platelet and Brain Fatty Acid Transfer: Hypothesis on Arachidonic Acid and its relationship to Major Depression. International Journal of Anthropology, 24: 201-220.\n\nCocchi M. Tonello L. Gabrielli F. (2009). Quantum consciousness and a-quantum consciousness. New Medicine, XIII, 4: 114-115.\n\nCocchi M. Tonello L. Gabrielli F. (2012). Considerations on Blood Platelets: A Neuron's Mirror for Mood Disorders? Open Journal of Blood Diseases, 2: 22-29.\n\nCocchi M. Tonello L. Gabrielli F. (2012). Possible Roles of Cell Membrane & Cytoskeleton in Quantum Aspect of Psychiatry Journal of Consciousness Exploration & Research, 3: 1082-1100.\n\nCocchi M. Tonello L. Gabrielli F. (2013). Platelet's Fatty Acids Secrets in Coronary Artery Disease (CAD). British Medical Journal, Letter to the Editor.\n\nCocchi M. Tonello L. Gabrielli F. Considerations on Blood Platelets: A Neuron's Mirror for Mood Disorders? Open Journal of Blood Diseases, doi:10.4236/ojbd.2012.22005.\n\nCocchi M. Tonello L. Gabrielli F. Pregnolato M. (2011). Depression, osteoporosis, serotonin and cell membrane viscosity between biology and philosophical anthropology. Annals of General Psychiatry, 10: 9.\n\nCocchi M. Tonello L. Gabrielli F. Pregnolato M. & Pessa E. (2011). Quantum Human & Animal Consciousness: A Concept Embracing Philosophy, Quantitative Molecular Biology & Mathematics. Journal of Consciousness Exploration & Research, 2: 547-574.\n\nCocchi M. Tonello L. Gabrielli F. Pregnolato M. Pessa E. (2011). Quantum human & animal consciousness: a concept embracing philosophy, quantitative molecular biology & mathematics. Journal of Consciousness Exploration & Research, 2: 547-74.\n\nCocchi M. Tonello L. Lercker G. (2009). Platelet Stearic Acid in different population groups: biochemical and functional hypothesis. Nutricion Clinica y Dietetica Hospitalaria, 29: 34-45.\n\nCocchi M. Tonello L. Lercker G. (2010). Fatty acids, membrane viscosity, serotonin and ischemic heart disease. Lipids in Health and Disease, 9:97.\n\nCocchi M. Tonello L. Martinez Alvarez J. Lercker G. Caramia G.M. (2009). Extra virgin olive oil and oleic acid. Nutricion Clinica y Dietetica Hospitalaria, 29: 12-24.\n\nCocchi M. Tonello L. Platelets, fatty acids, depression and cardiovascular ischemic pathology. Progr. Nutr. 9: 94-104, 2007.\n\nCocchi M. Tonello L. Rasenick Mark M. (2010). Human depression: a new approach in quantitative psychiatry. Annals of General Psychiatry. 9:25.\n\nCocchi M. Tonello L. Rasenick MM. (2010). Human depression: a new approach in quantitative psychiatry. Ann Gen Psychiatry, 9: 25.\n\nCocchi M. Tonello L. Tsaluchidu S. Puri B.K. (2008). The use of artificial neural networks to study fatty acids in neuropsychiatric disorders. BMC Psychiatry, 8 (Suppl 1): S3.\n\nCocchi M. Tonello L. Tsaluchidu S. Puri B.K. (2008). The use of self-organizing maps to study fatty acids in neuropsychiatric disorders. BMC Psychiatry, 8:S3.\n\nCocchi M. Turchetto E. (1999). Polyunsaturated fatty acids (LCPs) and perinatal development; Progress In Nutrition 1, 1.\n\nCocchi M., Tonello L., Capello G., Nabacino L., Passi S., Baldini N., Soreca I., Paffetti I., Castrogiovanni P., Tarozzi G.. (2006). Biochemical Markers in Major Depression as interface between Neuronal Network and Artificial Neural Network (ANN), J. Biol. Res., LXXXI, 77-81, 2006.\n\nCocchi M., Tonello L., Lercker G. (2009b). Platelet Stearic Acid in different population groups: biochemical and functional hypothesis. Nutricion Clinica y Dietetica Hospitalaria, 29: 34-45.\n\nCocchi M., Tonello L., Lercker G. (2010). Fatty acids, membrane viscosity, serotonin and ischemic heart disease. Lipids Health Dis., 9, 97-99.\n\nCocchi M., Tonello L., Martinez Alvarez J., Lercker G., Caramia G.M. (2009a). Extra virgin olive oil and oleic acid. Nutricion Clinica y Dietetica Hospitalaria, 29: 12-24.\n\nCocchi, M. Tonello, L. Gabrielli F., Levi D. & Pantaleoni G. (2012). Hypothesis on the Central Role of Serotonin in Biological and Anthropological Creation Journal of Consciousness Exploration & Research, 3: 1-19.\n\nCocchi, M., & Tonello, L. (2006). Biological, Biochemical and Mathematical Considerations about the Use of an Artificial Neural Network (ANN) for the Study of the Connection between Platelet Fatty Acids and Major Depression. Journal of Biological Research, 81, 82-87.\n\nCocchi, M., & Tonello, L. (2007). Platelets, Fatty Acids, Depression and Cardiovascular Ischemic Pathology. Progress in Nutrition, 9, 94-104.\n\nCocchi, M., & Tonello, L. (2010a). Bio Molecular Considerations in Major Depression and Ischemic Cardiovascular Disease. Central Nervous System Agents in Medicinal Chemistry, 10, 97-107. http://dx.doi.org/10.2174/187152410791196378\n\nCocchi, M., & Tonello, L. (2010b). Running the Hypothesis of a Bio Molecular Approach to Psychiatric Disorder Characterization and Fatty Acids Therapeutical Choices. Annals of General Psychiatry, 9, S26. http://dx.doi.org/10.1186/1744-859X-9-S1-S26\n\nCocchi, M., Gabrielli, F., Tonello, L., & Pregnolato, M. (2010). The Interactome Hypothesis of Depression. NeuroQuantology, 8, 603-613.\n\nCocchi, M., Sardi, L., Tonello, L., & Martelli, G. (2009). Do Mood Disorders Play a Role on Pig Welfare? Italian Journal of Animal Science, 8, 691-704.\n\nCocchi, M., Tonello, L. (2010) Bio molecular considerations in Major Depression and Ischemic Cardiovascular Disease. Central Nervous System Agents in Medicinal Chemistry, 10(2), 97-107. (doi: http://dx.doi.org/10.2174/187152410791196378).\n\nCocchi, M., Tonello, L. and Gabrielli, F. (2014) Mood Psychopathologies: An Integrated Complexity- Based Interpretation. Psychology, 5, 192-203.\n\nCocchi, M., Tonello, L., & Cappello, G. (2006). Biochemical Markers in Major Depression as Interface between Neuronal Network and Artificial Neural Network (ANN). Journal of Biological Research, 81, 77-81.\n\nCocchi, M., Tonello, L., & Gabrielli, F. (2012). Considerations on Blood Platelets: A Neuron's Mirror for Mood Disorders? Open Journal of Blood Diseases, 2, 22-29. http://dx.doi.org/10.4236/ojbd.2012.22005\n\nCocchi, M., Tonello, L., & Lercker, G. (2010). Fatty Acids, Membrane Viscosity, Serotonin and Ischemic Heart Disease. Lipids in Health and Disease, 9, 97. http://dx.doi.org/10.1186/1476-511X-9-97\n\nCocchi, M., Tonello, L., & Rasenick, M. (2010). Human Depression: A New Approach in Quantitative Psychiatry. Annals of General Psychiatry, 9, 25. http://dx.doi.org/10.1186/1744-859X-9-25\n\nCocchi, M., Tonello, L., Cappello, G., Tarozzi, G., Nabacino, L., Pastorini, E., Bucciarelli, S., Solazzo, L., De luca, M., Visci, G., & Caramia, G. (2008). Membrane Platelet Fatty Acids: Biochemical Characterisation of the Ischemic Cardiovascular Disease, Characteristics of the Paediatric Age, through an Artificial Neural Network Interpretation. Medical and Surgical Pediatrics, 30, 25-30.\n\nCocchi, M., Tonello, L., De Lucia, A., & Amato, P. (2009a). Platelet and Brain Fatty Acids: A Model for the Classification of the Animals? Part 1. International Journal of Anthropology, 24, 69-76.\n\nCocchi, M., Tonello, L., De Lucia, A., & Amato, P. (2009b). Platelet and Brain Fatty Acids: A Model for the Classification of the Animals? Part 2. Platelet and Brain Fatty Acid Transfer: Hypothesis on Arachidonic\n\nCocchi, M., Tonello, L., De Lucia, A., Amato, P. (2009c) Platelet and Brain Fatty Acids: a model for the classification of the animals? Part 2. Platelet and Brain Fatty acid transfer: Hypothesis on Arachidonic Acidand its relationship to Major Depression, International Journal of Anthropology, 24, 201-220.\n\nCocchi, M., Tonello, L., De Lucia, A., Amato, P. 2009 Platelet and brain fatty acids: a model for the classification of the animals? Part 2. Platelet and brain fatty acid transfer: hypothesis on arachidonic acid and its relationship to major depression. International Journal of Anthropology 24, 201-220.\n\nCocchi, M., Tonello, L., Gabrielli, F. (2012a) Considerations on Blood Platelets: A Neuron's Mirror for Mood Disorders? Open Journal of Blood Diseases, 2, 22-29. (doi:10.4236/ojbd.2012.22005).\n\nCocchi, M., Tonello, L., Gabrielli, F. (2012b). The animal side of \"mood disorders\". Saarbrucken, Germany: LAP Lambert Academic Publishing\n\nCocchi, M., Tonello, L., Rasenick, M.M. (2010)Human depression: a new approach in quantitative psychiatry. Annals of General Psychiatry 9:25-33\n\nCocchi, M., Tonello, L., Tsaluchidu, S., Puri, B.K. (2008) The use of artificial neural networks to study fatty acids in neuropsychiatric disorders. BMC Psychiatry, 8(Suppl 1), S3. (doi:10.1186/1471-244X-8-S1-S3).\n\nCoelho AM, Fioramonti J, Bueno L (1998). Mast cell degranulation induces delayed rectal allodynia in rats: role of histamine and 5-HT. Dig Dis Sci. 43: 727-737;\n\nCohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLOS Med 2012; 9: e1001251\n\nColeman M. (1971).Platelet Serotonin in Disturbed Monkeys and Children. Clinical Proc. Children's Hospital 27, 187-194.\n\nColeman N.S. Foley S. Dunlop S.P. et al. (2006). Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol, 4: 874 - 881.\n\nCollins A.C. Wehner J.M. and Wilson W.R. (1993). Animal models of alcoholism: genetic strategies and neurochemical mechanisms. Biochemical Society Symposia. 59: 173 - 191.\n\nCollins S, Denou E, Verdu E, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 2009;41(12):850-853;\n\nCollins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nature Rev Microbiol 2012;10:735 - 42.\n\nCollins, S. M. & Bercik, P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136, 2003 - 2014 (2009).\n\nCommittee on Medical Aspects of Food Policy. Diet and cardiovascular disease: report of the panel on diet in relation to cardiovascular disease. 1984\n\nComparato G, Di Mario F. NDSG. Recurrent diverticulitis. J Clin Gastroenterol, 2008, 42: 1130-4.\n\nConly JM, Stein K, The production of menaquinones (vitamin K2) by intestinal bacteria and their role in maintaining coagulation homeostasis, “Prog Food Nutr Sci”, 1992, Oct-Dec, 16 (4): 307-43.\n\nConly JM, Stein K, Worobetz L, Rutledge-Harding S. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol 1994;89(6):915 - 923;\n\nConstantinides P. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995; 92:1083-1088;\n\nConti B, Tabarean I, Andrei C, Bartfai T (2004) Cytokines and fever. Front Biosci 9:1433–1449. Krueger JM, Obal FJ, Fang J, Kubota T, Taishi P (2001) The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 933:211–221;\n\nConway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci. 1987; 70:1–12\n\nCoogan P.F. Strom B.L. Rosenberg L. (2009). Antidepressant use and colorectal cancer risk. Pharmacoepidemiol Drug Saf, 18: 1111 - 1114.\n\nCooper MA, Fehniger TA, Caligiuri MA, The biology of human natural killer-cell subsets, “Trends Immunol”, 2001, Nov, 22 (11): 633-40.\n\nCorbillè AG, Coron E, Neunlist M, Derkinderen P, Lebouvier T, Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD, “Microbiologyopen”, 2015, April, 4 (2): 282-300. Published online 2015 Jan 22. doi: 10.1002/mbo3.237PMCID: PMC4398509\n\nCorcoran BM, Ross RP, Fitzgerald GF, Stanton C, Comparative survival of probiotic Lactobacilli spray-dried in the presence of prebiotic substances, “J Appl Microbiol”, 2004, 96 (5): 1024-39.\n\nCorr SC, Gahan CG, Hill C. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol 50: 380 - 388,2007.\n\nCorzo G. Gilliland S.E. (1999). Bile Salt Hydrolase Activity of Three Strains of Lactobacillus acidophilus. Journal of Dairy Science, 82: 472-480.\n\nCosta-Pinto FA, Basso AS, RussoM(2007) Role of mast cell degranulation in the neural correlates of the immediate allergic reaction in a murine model of asthma. Brain Behav Immun 21:783–790.\n\nCosta-Pinto, FA, et al. (2006) Neural correlates of IgE-mediated allergy. Ann N Y Acad Sci 1088:116–131. Metcalfe DD (2008) Mast cells and mastocytosis. Blood 112:946–956;\n\nCostedio M.M. Coates M.D. Danielson A.B. et al. (2008). Serotonin signaling in diverticular disease. J Gastrointest Surg, 12: 1439 - 1445.\n\nCotter PD, Hill C, Ross RP: Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005, 3:777-788;\n\nCotter PD, Ross RP, Hill C: Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 2013, 11:95-105\n\nCovas M.I. (2004). Olive oil and the cardiovascular system. Pharmacological Research. 55: 175 - 186.\n\nCowburn R.F. Marcusson J.O. Eriksson A. Wiehager B. O'Neill C. (1994). Adenylyl cyclase activity and G-protein subunit levels in postmortem frontalcortex of suicide victims. Brain Res, 633: 297-304.\n\nCraddock T.J.A. Tuszynski JA, Hameroff S. (2012). Cytoskeletal Signaling: Is Memory Encoded in Microtubule Lattices by CaMKII Phosphorylation? PLoS Comput Biol 8(3): e10024.21.\n\nCraddock T.J.A. Tuszynski JA. (2010). A critical assessment of the information processing capabilities of neuronal microtubules using coherent excitations. J Biol Phys. 36: 53-70.\n\nCraddock TJA, Priel A, Tuszynski JA. (2014). Keeping time: Could quantum beating in microtubules be the basis for the neural synchrony related to consciousness? Journal of Integrative Neuroscience, Vol. 13, No. 2 (2014) 1 - 19\n\nCrawford PA, Crowley JR, Sambandam N, Muegge BD, Costello EK, Hamady M, Knight R, Gordon JI. Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc Natl Acad Sci USA 106: 11276 - 11281, 2009.\n\nCremon C. Carini G. Wang B. et al. (2011). Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel .Syndrome. The American Journal of Gastroenterology, 106: 1290 - 1298.\n\nCremonini F. Delgado-Aros S. Camilleri M. (2003). Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil, 15: 79 - 86.\n\nCremonini F. Di Caro S. Nista E. C. Bartolozzi F. Capelli G. Gasbarrini G. Gasbarrini A. Meta-analysis: the effect of probiotic administration on antibiotic associated diarrhoea. Aliment Pharmacol Ther, 2002, 16: 1461 - 1467.\n\nCrews F.T. Nixon K. (2009). Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol. 44: 115-127.\n\nCross ML, Ganner A, Teilab D, Fray LM, Patterns of cytokine induction by Gram-positive and Gram-negative probiotic bacteria, “FEMS Immunol Med Microbiol”, 2004, Oct 1, 42 (2): 173-80.\n\nCruz, M. R., Graham, C. E., Gagliano, B. C., Lorenz, M. C. & Garsin, D. A. Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect. Immun. 2012; 81, 189 - 200;\n\nCryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gutmicrobiota on brain and behaviour. Nat Rev Neurosci 2012;13:701 - 12.\n\nCryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011;23:187 - 92.\n\nCsaba G., Bierbauer J. (1974) Investigation on the specificity of hormone receptors in Planarians. Gen. Comp. Endocrinol. 22: 132-134.\n\nCszysz A.H. Rasenick M.M. (2013). G-Protein Signaling, Lipid Rafts and the Possible Sites of Action for the Antidepressant Effects of N-3 Polyunsaturated Fatty Acids. CNS Neurol Disord Drug Targets. Apr 4.\n\nCu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CC, et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001; 33: 894–6.\n\nCummings JH, Englyst HN. Gastrointestinal effects of food carbohydrate. Am J Clin Nutr. 1995;61:938S–945S.\n\nCuri U. (2002). Endiadi. Figure della duplicità , Feltrinelli, Milano.\n\nCuri U. (2009). Meglio non essere nati. La condizione umana tra Eschilo e Nietzsche, Bollati Boringhieri, Torino.\n\nCutler JE, Deepe Jr GS, Klein BS: Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 2007, 5:13-28;\n\nCzysz, AH, Schappi, J. and Rasenick MM after chronic but not acute antidepressant treatment: Role of lipid raft and non-raft membrane microdomains (in press Neuropsychopharmacology)\n\nD. L. Arvans, S. R. Vavricka, H. Ren et al., “Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 288, no. 4, pp. G696–G704, 2005;\n\nD. Mender (2013). The Cunning of the Observable: Generaloizzed Fourier Duality, The Hard Problem, and Natural Kinds of Psychopathology. Quantum Biosystems, 5: 43-54.\n\nD. Taras, W. Vahjen, M. Macha, and O. Simon, “Performance, diarrhea incidence, and occurrence of Escherichia coli virulence genes during long-term administration of a probiotic Enterococcus faecium strain to sows and piglets,” Journal of Animal Science, vol. 84, no. 3, pp. 608–617, 2006;\n\nD. U. Silverthorn, Fisiologia umana, Casa Editrice Ambrosiana (2000)\n\nDa Silva EZ, Jamur MC, Oliver C, Mast cell function: a new vision of an old cell, “J Histochem Cytochem.”, 2014, Oct, 62 (10): 698-738. doi: 10.1369/0022155414545334. Epub 2014 Jul 25.\n\nDai ZL, Wu G, Zhu WY, Amino acid metabolism in intestinal bacteria: links between gut ecology and host health, “Front Biosci (Landmark Ed)”, 2011 Jan 1, 16: 1768-86.\n\nDal sito www.genolevures.org/yeastgenomes.\n\nDaley TD. Armstrong JE. Oral manifestations of gastrointestinal diseases. Can J Gastroenterol 2007;21(4):241-244.\n\nDambekodi P.C. and Gilliland S. E. (1998). Incorporation of cholesterol into the cellular membrane of Bifidobacterium longum. J. Dairy Sci, 81: 1818 - 1824.\n\nDanese A, Pariante CM, Caspi A, Taylor A, Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U S A 2007;104:1319 - 1324.\n\nDantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008; 9:46-56;\n\nDarling WM: Co-cultivation of mycobacteria and fungus. Lancet 1976 2:740;\n\nDarwich AS, Aslam U, Ashcroft DM, Rostami-Hodjegan A, Meta-analysis of the turnover of intestinal epithelia in preclinical animal species and humans, “Drug Metab Dispos”, 2014, Dec, 42 (12): 2016-22. doi: 10.1124/dmd.114.058404. Epub 2014 Sep 18.\n\nDass NB, John AK, Bassil AK, et al. The relationship between the effects of short - chain fatty acids on intestinal motility in vitro and GPR43 receptor activation. Neurogastroenterol Motil. 2007;19: 66–74.\n\nDave, RH, Saengsawang,W., Lopus, M., Dave,S., Wilson,L. and Rasenick, M.M. (2011). A molecular and structural mechanism for G-protein mediated microtubule destabilization. J. Biol. Chem 286:4319-28\n\nDavid M, Albert and Gustav Döderlein - a critical view to the biographies of two German professors, “Zentralbl Gynakol”, 2006, Apr, 128 (2): 56-9.\n\nDavidson M.H. Hunninghake D. Maki K.C. et al. (1999). Comparison of the effects of lean red meat vs. lean white meat on serum lipid levels among free-living persons with hypercholesterolemia. Arch. Intern. Med. 159: 1331-1338.\n\nde Almeida DJ, de Aguilar - Nascimento JE, Nascimento M et al. Bacterial translocation in experimental uremia. Urol Res 2004; 32: 266–270.\n\nDe Angelis M, Rizzello CG, Scala E, De Simone C, Farris GA, Turrini F, Gobbetti M, Probiotic preparation has the capacity to hydrolyze proteins responsible for wheat allergy, “J Food Prot”, 2007, Jan, 70 (1): 135-44.\n\nde Graaf J. Hak-Lemmers H.L. Hectors M.P. Demacker P.N. Hendriks J.C. Stalenhoef A.F. (1991). Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb, 11:298-306.\n\nde Graaf J. Swinkels D.W. Demacker P.N. de Haan A.F. Stalenhoef A.F. (1993). Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls. J Clin Endocrinol Metab, 76:197-202.\n\nde Jong W.H.A. de Vries E.G.E. Kema I.P. (2009). Serotonin rising. N Engl J Med, 360(24):2580-1.\n\nde Meer G, Janssen NAH, Brunekreef B. Early childhood environment related to microbial exposure and the occurrence of atopic disease at school age. Allergy 2005;60(5):619 - 625;\n\nde Mello CF, Rubin MA, Coelho J, Wajner M, Souza DO, Effects of methylmalonate and propionate on [3H]glutamate binding, adenylate cyclase activity and lipid synthesis in rat cerebral cortex, “Biochem Mol Biol Int”, 1997, Sep, 42 (6): 1143-50.\n\nDe Monticelli R. (2009). La novità di ognuno. Persona e libertà , Garzanti, Milano.\n\nDe Ninno, A., Congiu Castellano, A. (2011) Deprotonation of Glutamic Acid Induced by Weak Magnetic field: an FTIR-ATR Study, Bioelectromagnetics, 32:218-225.\n\nDe Peters E.J. German J.B. Taylor S.J. Essex S.T. & Perez-Monti H. (2001). Fatty acid and triglyceride composition from lactating Holstein cows in response to supplemental canola oil. J. Dairy Sci. 84: 929 - 936.\n\nDe Pinieux G. Chariot P. Ammi-Said M. et al. (1996). Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. British Journal of Clinical Pharmacology, 42: 333 - 7.\n\nde Roos N.M. Katan M.B. (2000). Effects of Probiotic Bacteria on Diarrhea, Lipid Metabolism, and Carcinogenesis: A Review of Papers American Journal of Clinical Nutrition, 71: 405-11.\n\nDe Santis A. Famularo G. De Simone C. Probiotics for the hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol, 2000, 95: 323-4.\n\nde Vries, H. S. et al. Genetic association analysis of the functional c.714T>G. polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease. PLoS ONE 2009; 4, e7818;\n\nDeborah AH, Roberto K: Fungal-bacterial interactions. In Molecular Principles of Fungal Pathogenesis. Edited by Heitman J, Filler SG, Edwards JE, Mitchell AP. Washington DC: ASM Press; 2006:261-269;\n\nDeBose-Boyd, R. A. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18:609–621; 2008\n\nDeepika Priyadarshani, W. M. and Rakshit, S. K. (2011), Screening selected strains of probiotic lactic acid bacteria for their ability to produce biogenic amines (histamine and tyramine). International Journal of Food Science & Technology, 46: 2062 - 2069. doi: 10.1111/j.1365-2621.2011.02717.\n\nDeFaria Yeh D1, Freeman MW, Meigs JB, Grant RW. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol. Am J Cardiol. 2007 Jan 1;99(1):1-4. Epub 2006 Nov 2.\n\nDefinition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109: 34–43.\n\nDeGeorge J. J. Noronha J. G. Bell J. Robinson P. & Rapaport S. I. (1989). J. Neurosci. Res. 24: 423-427.\n\nDel Giudice, E., Preparata, G., Vitiello, G. (1988) Water as a free electric dipole laser Phys. Rev. Lett. 61, 1085.\n\nDelhaes L, Monchy S, Fralle E, Hubans C, Salleron J, Leroy S, Prevotat A, Wallet F, Wallaert B, Dei-Cas E: The airway microbiota in cystic fibrosis: a complex fungal and bacterial community - implications for therapeutic management. PLoS One 2012, 7:e36313;\n\nDelzenne NM, Cani PD. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 2011; 31: 15– 31;\n\nDelzenne NM, Neyrinck AM, Backhed F, et al. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 2011; 7: 639–46;\n\nDeMaria, A., Buckley, H. & von Lichtenberg, F. Gastrointestinal candidiasis in rats treated with antibiotics, cortisone, and azathioprine. Infect. Immun. 1976; 13, 1761 - 1770;\n\nDemetrius, L.and Tuszynski, J.A. (2010) Quantum metabolism explains the allometric scaling of metabolic rates. J R Soc Interface 7:507-514.\n\nDemirel, G. et al. Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. Eur. J. Pediatr. 2013; 172, 1321 - 1326.\n\nDen Hond E, Hiele M, Evenepoel P, et al. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 1998; 115:584 - 90.\n\nDendukuri N, Costa V, McGregor M, Brophy J. Probiotic therapy for the prevention and treatment of Clostridium difficile–associated diarrhea: a systematic review. CMAJ. 2005; 173:167-170;\n\nDere E, et al. (2004) Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice.Eur J Neurosci 20:1051–1058.\n\nDereje Damte, Md. Ahsanur Reza, Woo-Sik Jo, and Seung-Chun Park.Anti-inflammatory Activity of Dichloromethane Extract of Auricularia auricula-judae in RAW264.7 Cells Toxicol Res. 2011 Mar; 27(1): 11 - 14.\n\nDesbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects ofthe probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010;170:1179 - 88.\n\nDethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6(11):e280\n\nDethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007;449: 811–8.\n\nDev, S., Mizuguchi, H., Das, A. K., Matsushita, C., Maeyama, K., Umehara, H., ... & Fukui, H. (2008). Suppression of histamine signaling by probiotic Lac-B: a possible mechanism of its anti-allergic effect. Journal of pharmacological sciences, 107(2), 159-166.\n\nDewettinck K. Rombaut R., Thienpont N. Le T.T. Messens K. Van Camp J. (2008). Nutritional and technological aspects of milk fat globule membrane material. International Dairy Journal. 18: 436 - 457.\n\nDewhirst FE, Chien CC, Paster BJ, Ericson RL, Orcutt RP, Schauer DB, Fox JG. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 65: 3287 - 3292, 1999.\n\nDey A. Cederbaum A.I. (2006). Alcohol and oxidative liver injury. Hepatology. 43: S63-S74.\n\nDhakal R, Bajpai VK, Baek KH, Production of gaba (γ-Aminobutyric acid) by microorganisms: a review, “Braz J Microbiol”, 2012, Oct, 43 (4): 1230-41. doi: 10.1590/S1517-83822012000400001. Epub 2012, Jun 1.\n\nDhanani AS, Bagchi T,The expression of adhesin EF-Tu in response to mucin and its role in Lactobacillus adhesion and competitive inhibition of enteropathogens to mucin, “J Appl Microbiol”, 2013, Aug, 115 (2): 546-54. doi: 10.1111/jam.12249. Epub 2013 Jun 3.\n\nDial S, Delaney JA, Barkun AN, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294(23):2989–95;\n\nDickson RP, et al. The role of the microbiome in lung disease. Exp. Rev. Respir. Med. 2013; 7;\n\nDiefenbach R., Heipieper H-J., Keweloh H. (1992). The conversion of cis into trans unsaturated fatty acids in Pseudomonas putita P8: evidence for a role in the regulation of membrane fluidity. Appl. Microbiol. Biotechnol., 38:382-387\n\nDieterich W, Esslinger B, Trapp D, Hahn E, Huff T, Seilmeier W, Wieser H, Schuppan D, Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease, “Gut”, 2006, Apr, 55 (4): 478-84. Epub 2005 Sep 27.\n\nDimitriadou V, Lambr"
    }
}